JAMIE THACKER: Open Payments
NPI 1548998131 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 27 payments from 11 companies in 2025. Trend: 2023 $33 · 2024 $326 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $118 |
| Novo Nordisk Inc | 5 | $83 |
| PFIZER INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Insulet Corporation | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: JARDIANCE, MOUNJARO, Ozempic, AIRSUPRA, NURTEC ODT, Rybelsus, Kerendia, REXULTI.
Industry payments across IN — which companies pay providers there.
